Citation tools
"Phase II randomised, double-blind, placebo-controlled trial to assess the efficacy and safety of MLC1501 in patients with stroke: the MLC1501 study Assessing Efficacy in post-STrOke Subjects with mOtor deficits (MAESTOSO) study protocol." Stroke and Vascular Neurology
(2025):
svn-2024-003750.
Web. 04 May. 2025.